BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34762934)

  • 21. Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 Expression.
    Tatler AL; Habgood A; Porte J; John AE; Stavrou A; Hodge E; Kerama-Likoko C; Violette SM; Weinreb PH; Knox AJ; Laurent G; Parfrey H; Wolters PJ; Wallace W; Alberti S; Nordheim A; Jenkins G
    J Biol Chem; 2016 Apr; 291(18):9540-53. PubMed ID: 26861876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Integrin Inhibitor Cilengitide and Bleomycin-Induced Pulmonary Fibrosis : Cilengitide and Bleomycin-Induced Pulmonary Fibrosis.
    Ritzenthaler JD; Zhang M; Torres-Gonzalez E; Roman J
    Lung; 2020 Dec; 198(6):947-955. PubMed ID: 33146772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment.
    Brzozowska E; Deshmukh S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo.
    Eberlein C; Kendrew J; McDaid K; Alfred A; Kang JS; Jacobs VN; Ross SJ; Rooney C; Smith NR; Rinkenberger J; Cao A; Churchman A; Marshall JF; Weir HM; Bedian V; Blakey DC; Foltz IN; Barry ST
    Oncogene; 2013 Sep; 32(37):4406-16. PubMed ID: 23108397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.
    Lee JH; Lee CM; Lee JH; Kim MO; Park JW; Kamle S; Akosman B; Herzog EL; Peng XY; Elias JA; Lee CG
    Am J Respir Cell Mol Biol; 2022 Sep; 67(3):309-319. PubMed ID: 35679109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrin αvβ6: Structure, function and role in health and disease.
    Koivisto L; Bi J; Häkkinen L; Larjava H
    Int J Biochem Cell Biol; 2018 Jun; 99():186-196. PubMed ID: 29678785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical quantification of the integrin αvβ6 by [
    Lukey PT; Coello C; Gunn R; Parker C; Wilson FJ; Saleem A; Garman N; Costa M; Kendrick S; Onega M; Kang'ombe AR; Listanco A; Davies J; Ramada-Magalhaes J; Moz S; Fahy WA; Maher TM; Jenkins G; Passchier J; Marshall RP
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):967-979. PubMed ID: 31814068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of Oxidative Phosphorylation with IM156 Attenuates Mitochondrial Metabolic Reprogramming and Inhibits Pulmonary Fibrosis.
    Willette RN; Mangrolia P; Pondell SM; Lee CYW; Yoo S; Rudoltz MS; Cowen BR; Welsch DJ
    J Pharmacol Exp Ther; 2021 Nov; 379(3):290-300. PubMed ID: 34593558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in mice.
    Pi L; Robinson PM; Jorgensen M; Oh SH; Brown AR; Weinreb PH; Trinh TL; Yianni P; Liu C; Leask A; Violette SM; Scott EW; Schultz GS; Petersen BE
    Hepatology; 2015 Feb; 61(2):678-91. PubMed ID: 25203810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
    Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterisation of a tool αvβ1 integrin small molecule RGD-mimetic inhibitor.
    Wilkinson AL; Barrett JW; Slack RJ
    Eur J Pharmacol; 2019 Jan; 842():239-247. PubMed ID: 30389632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
    Divya T; Velavan B; Sudhandiran G
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of integrin αvβ6 leads to rapid induction of urinary bladder tumors in cynomolgus macaques.
    Guffroy M; Trela B; Kambara T; Stawski L; Chen H; Luus L; Montesinos MS; Olson L; He Y; Maisonave K; Carr T; Lu M; Ray AS; Hazelwood LA
    Toxicol Sci; 2023 Feb; 191(2):400-413. PubMed ID: 36515490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production.
    Tabata T; Kawakatsu H; Maidji E; Sakai T; Sakai K; Fang-Hoover J; Aiba M; Sheppard D; Pereira L
    Am J Pathol; 2008 Apr; 172(4):1127-40. PubMed ID: 18349127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor.
    Maher TM; Simpson JK; Porter JC; Wilson FJ; Chan R; Eames R; Cui Y; Siederer S; Parry S; Kenny J; Slack RJ; Sahota J; Paul L; Saunders P; Molyneaux PL; Lukey PT; Rizzo G; Searle GE; Marshall RP; Saleem A; Kang'ombe AR; Fairman D; Fahy WA; Vahdati-Bolouri M
    Respir Res; 2020 Mar; 21(1):75. PubMed ID: 32216814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis.
    Goodwin A; Jenkins G
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):849-54. PubMed ID: 19614606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins.
    Monieri M; Rainone P; Sacchi A; Gori A; Gasparri AM; Coliva A; Citro A; Ferrara B; Policardi M; Valtorta S; Pocaterra A; Alfano M; Sheppard D; Piemonti L; Moresco RM; Corti A; Curnis F
    Int J Biol Sci; 2023; 19(1):156-166. PubMed ID: 36594095
    [No Abstract]   [Full Text] [Related]  

  • 38. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling.
    Eberlein C; Rooney C; Ross SJ; Farren M; Weir HM; Barry ST
    Oncogene; 2015 Feb; 34(6):704-16. PubMed ID: 24488011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.
    Allen MD; Thomas GJ; Clark S; Dawoud MM; Vallath S; Payne SJ; Gomm JJ; Dreger SA; Dickinson S; Edwards DR; Pennington CJ; Sestak I; Cuzick J; Marshall JF; Hart IR; Jones JL
    Clin Cancer Res; 2014 Jan; 20(2):344-57. PubMed ID: 24150233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.